EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma

Cristina Valero, Mahdi Golkaram, Joris L Vos, Bin Xu, Conall Fitzgerald, Mark Lee, Shannon Kaplan, Catherine Y Han, Xin Pei, Reith Sarkar, Lillian A Boe, Abhinav Pandey und 10 weitere

Journal of Clinical Investigation · 02.10.2023 · 133 (19)

DOI: 10.1172/jci169823 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.10.2023. Verfasst von Cristina Valero und 21 weiteren Autor:innen. Beteiligte Einrichtung: Head and Neck Service, Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, US…. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Head and Neck Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDCR NIH HHS, Fundación Alfonso Martín Escudero.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsHead and Neck NeoplasmsHumansSquamous Cell Carcinoma of Head and NeckMutationBiomarkers, TumorGenomics

Stichwörter der Autor:innen

Cancer immunotherapyHead and neck cancerImmunologyOncology

Substanzen

Immune Checkpoint InhibitorsBiomarkers, Tumor

Autor:innen und Institutionen

  • Head and Neck Service, Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, USA.
  • Illumina Inc., San Diego, California, USA.
  • Department of Pathology and Laboratory Medicine.
  • Department of Radiation Oncology, and.
  • Department of Biostatistics and Epidemiology, MSKCC, New York, New York, USA.
  • Department of Head and Neck Oncology and Surgery, Antoni van Leeuwenhoek Hospital-Netherlands Cancer Institute, Amsterdam, Netherlands.

Förderung

  • NCI NIH HHS
  • NIDCR NIH HHS
  • Fundación Alfonso Martín Escudero
  • NIH
  • Geoffrey Beene Cancer Research Center
  • Jayme and Peter Flowers Fund
  • Sebastian Nativo Fund
  • NIH/NCI

Zitieren

APA

Valero, C., Golkaram, M., Vos, J. L., Xu, B., Fitzgerald, C., Lee, M., Kaplan, S., Han, C. Y., Pei, X., Sarkar, R., Boe, L. A., Pandey, A., Koh, E. S., Zuur, C. L., Solit, D. B., Pawlowski, T., Liu, L., Ho, A. L., Chowell, D., …, & Morris, L. G. (2023). Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma. Journal of Clinical Investigation, 133(19). https://doi.org/10.1172/jci169823

Vancouver

Valero C, Golkaram M, Vos JL, Xu B, Fitzgerald C, Lee M, et al. Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma. Journal of Clinical Investigation. 2023;133(19). doi:10.1172/jci169823

BibTeX
@article{Valero2023,
  author = {Valero, Cristina and Golkaram, Mahdi and Vos, Joris L and Xu, Bin and Fitzgerald, Conall and Lee, Mark and Kaplan, Shannon and Han, Catherine Y and Pei, Xin and Sarkar, Reith and Boe, Lillian A and Pandey, Abhinav and Koh, Elizabeth S and Zuur, Charlotte L and Solit, David B and Pawlowski, Traci and Liu, Li and Ho, Alan L and Chowell, Diego and Riaz, Nadeem and Chan, Timothy A and Morris, Luc Gt},
  title = {Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma},
  journal = {Journal of Clinical Investigation},
  year = {2023},
  volume = {133},
  number = {19},
  doi = {10.1172/jci169823}
}
Kostenlos starten →